In the last 12 months, insiders at Apogee Therapeutics, Inc. ($APGE) filed 169 transactions with the SEC: 7 open-market purchases totaling $80,740,808 and 103 sales totaling $162,457,652. Net insider sentiment: net selling.
Apogee Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Fairmount Funds Management LLC (Director) — 17 transactions totaling $183,524,992
- Shah Nimish P (Director) — 4 transactions totaling $29,750,000
- HENDERSON MICHAEL THOMAS (Chief Executive Officer) — 42 transactions totaling $19,915,009
- Dambkowski Carl (Chief Medical Officer) — 69 transactions totaling $8,350,784
- Henderson Jane (Chief Financial Officer) — 20 transactions totaling $1,868,266
View all SEC Filings for Apogee Therapeutics, Inc. (APGE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $85.00 | 179,371.0000 | 68,320,229 | 1.10% | 0.00% |
| March 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 3418 | $75.86 | 1,152,987.0000 | 68,320,229 | 0.30% | 0.01% |
| March 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 8363 | $74.29 | 1,164,624.0000 | 68,320,229 | 0.71% | 0.01% |
| March 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 8219 | $74.83 | 1,156,405.0000 | 68,320,229 | 0.71% | 0.01% |
| March 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 3225 | $70.33 | 212,048.0000 | 68,320,229 | 1.50% | 0.00% |
| March 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2075 | $71.98 | 209,973.0000 | 68,320,229 | 0.98% | 0.00% |
| March 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 200 | $73.26 | 209,773.0000 | 68,320,229 | 0.10% | 0.00% |
| March 4, 2026 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 4125 | $0.00 | 131,290.0000 | 68,320,229 | 3.05% | 0.01% |
| March 4, 2026 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 4125 | $22.86 | 215,273.0000 | 68,320,229 | 1.95% | 0.01% |
| March 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 300 | $68.27 | 183,071.0000 | 68,320,229 | 0.16% | 0.00% |
| March 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 300 | $69.43 | 182,771.0000 | 68,320,229 | 0.16% | 0.00% |
| March 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 994 | $70.45 | 181,777.0000 | 68,320,229 | 0.54% | 0.00% |
| March 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 406 | $71.66 | 181,371.0000 | 68,320,229 | 0.22% | 0.00% |
| Feb. 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 11494 | $62.96 | 1,181,493.0000 | 68,320,229 | 0.96% | 0.02% |
| Feb. 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 7551 | $63.73 | 1,173,942.0000 | 68,320,229 | 0.64% | 0.01% |
| Feb. 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 955 | $64.99 | 1,172,987.0000 | 68,320,229 | 0.08% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 4125 | $0.00 | 135,415.0000 | 68,320,229 | 2.96% | 0.01% |
| Feb. 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 100 | $66.89 | 183,371.0000 | 68,320,229 | 0.05% | 0.00% |
| Feb. 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1108 | $66.15 | 183,471.0000 | 68,320,229 | 0.60% | 0.00% |
| Feb. 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 792 | $65.21 | 184,579.0000 | 68,320,229 | 0.43% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 200 | $68.94 | 211,148.0000 | 68,320,229 | 0.09% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 100 | $67.88 | 211,348.0000 | 68,320,229 | 0.05% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 1299 | $66.85 | 211,448.0000 | 68,320,229 | 0.61% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 1420 | $65.83 | 212,747.0000 | 68,320,229 | 0.66% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2481 | $64.88 | 214,167.0000 | 68,320,229 | 1.15% | 0.00% |
| Feb. 4, 2026 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 4125 | $22.86 | 216,648.0000 | 68,320,229 | 1.94% | 0.01% |
| Jan. 22, 2026 | Fairmount Funds Management LLC | Director | S | Common Stock | 1750000 | $76.30 | 400,979.0000 | 68,320,229 | 81.36% | 2.56% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 8476 | $79.82 | 1,203,071.0000 | 68,320,229 | 0.70% | 0.01% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 1440 | $78.64 | 1,211,547.0000 | 68,320,229 | 0.12% | 0.00% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 2374 | $81.00 | 1,200,697.0000 | 68,320,229 | 0.20% | 0.00% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 5386 | $83.16 | 1,193,457.0000 | 68,320,229 | 0.45% | 0.01% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 470 | $83.79 | 1,192,987.0000 | 68,320,229 | 0.04% | 0.00% |
| Jan. 14, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 1854 | $82.41 | 1,198,843.0000 | 68,320,229 | 0.15% | 0.00% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 14820 | $77.90 | 213,449.0000 | 68,320,229 | 6.49% | 0.02% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2954 | $77.13 | 228,269.0000 | 68,320,229 | 1.28% | 0.00% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 14025 | $22.86 | 231,223.0000 | 68,320,229 | 6.46% | 0.02% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 14025 | $0.00 | 139,540.0000 | 68,320,229 | 9.13% | 0.02% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 100 | $80.06 | 212,523.0000 | 68,320,229 | 0.05% | 0.00% |
| Jan. 7, 2026 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 826 | $79.04 | 212,623.0000 | 68,320,229 | 0.39% | 0.00% |
| Jan. 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 4080 | $75.20 | 187,371.0000 | 68,320,229 | 2.13% | 0.01% |
| Jan. 2, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | A | Stock Option (Right to Buy) | 253016 | $0.00 | 253,016.0000 | 68,320,229 | 9999.99% | 0.37% |
| Jan. 2, 2026 | Dambkowski Carl | Chief Medical Officer | A | Stock Option (Right to Buy) | 83690 | $0.00 | 83,690.0000 | 68,320,229 | 9999.99% | 0.12% |
| Jan. 2, 2026 | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 83690 | $0.00 | 83,690.0000 | 68,320,229 | 9999.99% | 0.12% |
| Jan. 6, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $80.00 | 185,371.0000 | 68,320,229 | 1.07% | 0.00% |
| Jan. 2, 2026 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1920 | $74.13 | 191,451.0000 | 68,320,229 | 0.99% | 0.00% |
| Dec. 19, 2025 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $80.00 | 193,371.0000 | 68,320,229 | 0.77% | 0.00% |
| Dec. 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 560 | $76.58 | 1,212,987.0000 | 68,320,229 | 0.05% | 0.00% |
| Dec. 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 9435 | $74.88 | 1,223,552.0000 | 68,320,229 | 0.77% | 0.01% |
| Dec. 10, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 10005 | $75.79 | 1,213,547.0000 | 68,320,229 | 0.82% | 0.01% |
| Dec. 4, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 10900 | $75.00 | 271,108.0000 | 68,320,229 | 3.87% | 0.02% |
| Dec. 4, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 40000 | $75.01 | 1,232,987.0000 | 68,320,229 | 3.14% | 0.06% |
| Dec. 4, 2025 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $75.00 | 194,871.0000 | 68,320,229 | 0.76% | 0.00% |
| Nov. 25, 2025 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $70.00 | 196,371.0000 | 68,320,229 | 0.76% | 0.00% |
| Nov. 14, 2025 | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $65.00 | 197,871.0000 | 68,320,229 | 1.00% | 0.00% |
| Nov. 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 14774 | $63.14 | 1,274,873.0000 | 68,320,229 | 1.15% | 0.02% |
| Nov. 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 100 | $64.52 | 1,272,987.0000 | 68,320,229 | 0.01% | 0.00% |
| Nov. 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 1786 | $63.89 | 1,273,087.0000 | 68,320,229 | 0.14% | 0.00% |
| Nov. 13, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 3340 | $61.93 | 1,289,647.0000 | 68,320,229 | 0.26% | 0.00% |
| Nov. 11, 2025 | Henderson Jane | Chief Financial Officer | S | Common Stock | 1000 | $60.00 | 199,871.0000 | 68,320,229 | 0.50% | 0.00% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 678 | $56.51 | 282,008.0000 | 68,320,229 | 0.24% | 0.00% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 8060 | $0.00 | 153,565.0000 | 68,320,229 | 4.99% | 0.01% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2300 | $53.62 | 290,493.0000 | 68,320,229 | 0.79% | 0.00% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 8060 | $22.86 | 292,793.0000 | 68,320,229 | 2.83% | 0.01% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2200 | $54.83 | 288,293.0000 | 68,320,229 | 0.76% | 0.00% |
| Nov. 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 5607 | $55.58 | 282,686.0000 | 68,320,229 | 1.94% | 0.01% |
| Oct. 10, 2025 | Shah Nimish P | Not found | P | Pre-Funded Warrants (Right to Buy) | 365853 | $41.00 | 365,853.0000 | 46,016,542 | 9999.99% | 0.80% |
| Oct. 1, 2025 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 2385 | $22.86 | 289,843.0000 | 46,016,542 | 0.83% | 0.01% |
| Oct. 1, 2025 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 2385 | $0.00 | 161,625.0000 | 46,016,542 | 1.45% | 0.01% |
| Oct. 1, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 5110 | $39.80 | 284,733.0000 | 46,016,542 | 1.76% | 0.01% |
| Sept. 3, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2535 | $37.82 | 233,738.0000 | 46,016,542 | 1.07% | 0.01% |
| Sept. 3, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 190 | $38.55 | 233,548.0000 | 46,016,542 | 0.08% | 0.00% |
| Aug. 6, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2725 | $37.78 | 236,273.0000 | 46,016,542 | 1.14% | 0.01% |
| July 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2935 | $45.49 | 239,744.0000 | 46,016,542 | 1.21% | 0.01% |
| July 2, 2025 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 7365 | $22.86 | 249,088.0000 | 46,016,542 | 3.05% | 0.02% |
| July 2, 2025 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 7365 | $0.00 | 164,010.0000 | 46,016,542 | 4.30% | 0.02% |
| July 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 746 | $46.26 | 238,998.0000 | 46,016,542 | 0.31% | 0.00% |
| July 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 6409 | $44.77 | 242,679.0000 | 46,016,542 | 2.57% | 0.01% |
| June 17, 2025 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 28,922.0000 | 46,016,542 | 100.00% | 0.03% |
| June 17, 2025 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 28,922.0000 | 46,016,542 | 100.00% | 0.03% |
| June 17, 2025 | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 17, 2025 | McKenna Mark C. | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 17, 2025 | JONES WILLIAM A JR | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 17, 2025 | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 17, 2025 | Fox Jennifer A. | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 17, 2025 | Bollinger Lisa | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 4, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2725 | $36.96 | 241,723.0000 | 46,016,542 | 1.11% | 0.01% |
| May 7, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2725 | $35.75 | 244,448.0000 | 46,016,542 | 1.10% | 0.01% |
| April 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 889 | $37.59 | 247,173.0000 | 46,016,542 | 0.36% | 0.00% |
| April 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2471 | $35.56 | 248,562.0000 | 46,016,542 | 0.98% | 0.01% |
| April 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 500 | $37.03 | 248,062.0000 | 46,016,542 | 0.20% | 0.00% |
| March 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 2674 | $30.62 | 1,292,987.0000 | 46,016,542 | 0.21% | 0.01% |
| March 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 1590 | $30.48 | 251,033.0000 | 46,016,542 | 0.63% | 0.00% |
| March 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 7326 | $29.98 | 1,295,661.0000 | 46,016,542 | 0.56% | 0.02% |
| Feb. 5, 2025 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 795 | $22.86 | 256,143.0000 | 0 | 0.31% | 0.00% |
| Feb. 5, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 3520 | $40.69 | 252,623.0000 | 0 | 1.37% | 0.00% |
| Feb. 5, 2025 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 795 | $0.00 | 171,375.0000 | 0 | 0.46% | 0.00% |
| Feb. 5, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 15000 | $40.58 | 1,302,987.0000 | 0 | 1.14% | 0.00% |
| Jan. 31, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | M | Stock Option (Right to Buy) | 8500 | $0.00 | 390,012.0000 | 0 | 2.13% | 0.00% |
| Jan. 31, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | M | Common Stock | 8500 | $22.86 | 1,317,987.0000 | 0 | 0.65% | 0.00% |
| Jan. 8, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 12132 | $48.72 | 1,312,355.0000 | 0 | 0.92% | 0.00% |
| Jan. 8, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 2868 | $49.38 | 1,309,487.0000 | 0 | 0.22% | 0.00% |
| Jan. 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 100 | $47.92 | 255,348.0000 | 0 | 0.04% | 0.00% |
| Jan. 2, 2025 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 1360 | $22.86 | 259,433.0000 | 0 | 0.53% | 0.00% |
| Jan. 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 1499 | $46.42 | 257,934.0000 | 0 | 0.58% | 0.00% |
| Jan. 2, 2025 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2486 | $47.21 | 255,448.0000 | 0 | 0.96% | 0.00% |
| Jan. 2, 2025 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 1360 | $0.00 | 172,170.0000 | 0 | 0.78% | 0.00% |
| Dec. 12, 2024 | McKenna Mark C. | Director | P | Common Stock | 7500 | $49.02 | 7,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 12, 2024 | McKenna Mark C. | Director | P | Common Stock | 12500 | $49.85 | 20,000.0000 | 0 | 166.67% | 0.00% |
| Dec. 11, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 455 | $50.00 | 258,073.0000 | 0 | 0.18% | 0.00% |
| Dec. 11, 2024 | Dambkowski Carl | Chief Medical Officer | M | Common Stock | 1815 | $22.86 | 262,613.0000 | 0 | 0.70% | 0.00% |
| Dec. 11, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 4085 | $48.62 | 258,528.0000 | 0 | 1.56% | 0.00% |
| Dec. 11, 2024 | Dambkowski Carl | Chief Medical Officer | M | Stock Option (Right to Buy) | 1815 | $0.00 | 173,530.0000 | 0 | 1.04% | 0.00% |
| Dec. 9, 2024 | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 124962 | $0.00 | 124,962.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | A | Stock Option (Right to Buy) | 357036 | $0.00 | 357,036.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Dambkowski Carl | Chief Medical Officer | A | Stock Option (Right to Buy) | 124962 | $0.00 | 124,962.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 13328 | $46.50 | 1,326,159.0000 | 0 | 1.00% | 0.00% |
| Dec. 4, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 6665 | $46.07 | 260,798.0000 | 0 | 2.49% | 0.00% |
| Dec. 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 1672 | $47.19 | 1,324,487.0000 | 0 | 0.13% | 0.00% |
| Nov. 6, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 14000 | $59.17 | 1,340,487.0000 | 0 | 1.03% | 0.00% |
| Nov. 6, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 5326 | $58.91 | 268,802.0000 | 0 | 1.94% | 0.00% |
| Nov. 6, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 1339 | $59.96 | 267,463.0000 | 0 | 0.50% | 0.00% |
| Nov. 6, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 1000 | $59.94 | 1,339,487.0000 | 0 | 0.07% | 0.00% |
| Oct. 2, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 30288 | $56.07 | 1,364,199.0000 | 0 | 2.17% | 0.00% |
| Oct. 2, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 5740 | $56.16 | 275,053.0000 | 0 | 2.04% | 0.00% |
| Oct. 2, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 925 | $56.86 | 274,128.0000 | 0 | 0.34% | 0.00% |
| Oct. 2, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 9712 | $56.74 | 1,354,487.0000 | 0 | 0.71% | 0.00% |
| Sept. 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 25641 | $47.28 | 1,408,846.0000 | 0 | 1.79% | 0.00% |
| Sept. 4, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 5878 | $47.49 | 281,580.0000 | 0 | 2.04% | 0.00% |
| Sept. 4, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 787 | $48.06 | 280,793.0000 | 0 | 0.28% | 0.00% |
| Sept. 4, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 14359 | $48.23 | 1,394,487.0000 | 0 | 1.02% | 0.00% |
| Aug. 23, 2024 | Henderson Jane | Chief Financial Officer | S | Common Stock | 6000 | $48.26 | 200,871.0000 | 0 | 2.90% | 0.00% |
| Aug. 7, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 100 | $42.17 | 1,434,487.0000 | 0 | 0.01% | 0.00% |
| Aug. 7, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 6523 | $40.47 | 288,270.0000 | 0 | 2.21% | 0.00% |
| Aug. 7, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 142 | $41.09 | 288,128.0000 | 0 | 0.05% | 0.00% |
| Aug. 7, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 670 | $42.56 | 287,458.0000 | 0 | 0.23% | 0.00% |
| Aug. 7, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 32233 | $40.40 | 1,442,254.0000 | 0 | 2.19% | 0.00% |
| Aug. 7, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 7667 | $41.52 | 1,434,587.0000 | 0 | 0.53% | 0.00% |
| July 3, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 3852 | $37.29 | 296,936.0000 | 0 | 1.28% | 0.00% |
| July 5, 2024 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | S | Common Stock | 15000 | $37.26 | 1,474,487.0000 | 0 | 1.01% | 0.00% |
| July 3, 2024 | Dambkowski Carl | Chief Medical Officer | S | Common Stock | 2143 | $38.16 | 294,793.0000 | 0 | 0.72% | 0.00% |
| June 5, 2024 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | JONES WILLIAM A JR | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | McKenna Mark C. | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Bollinger Lisa | Director | A | Stock Option (Right to Buy) | 8112 | $0.00 | 8,112.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Fox Jennifer A. | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| May 28, 2024 | Bollinger Lisa | Director | A | Stock Option (Right to Buy) | 18550 | $0.00 | 18,550.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Director | J | Common Stock | 55913 | $0.00 | 2,150,979.0000 | 0 | 2.67% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Director | J | Common Stock | 55913 | $0.00 | 2,150,979.0000 | 0 | 2.53% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Director | J | Non-Voting Common Stock | 221426 | $0.00 | 6,743,321.0000 | 0 | 3.40% | 0.00% |
| March 28, 2024 | Fairmount Funds Management LLC | Director | J | Non-Voting Common Stock | 221426 | $0.00 | 6,743,321.0000 | 0 | 3.18% | 0.00% |
| Jan. 29, 2024 | Fairmount Funds Management LLC | Director | J | Common Stock | 51166 | $0.00 | 102,332.0000 | 0 | 100.00% | 0.00% |
| Jan. 29, 2024 | Fairmount Funds Management LLC | Director | J | Common Stock | 892529 | $0.00 | 102,332.0000 | 0 | 89.71% | 0.00% |
| Jan. 29, 2024 | Fairmount Funds Management LLC | Director | J | Common Stock | 51166 | $0.00 | 102,332.0000 | 0 | 100.00% | 0.00% |
| Dec. 18, 2023 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | A | Stock Option (Right to Buy) | 398512 | $0.00 | 398,512.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2023 | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 175345 | $0.00 | 175,345.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2023 | Dambkowski Carl | Chief Medical Officer | A | Stock Option (Right to Buy) | 175345 | $0.00 | 175,345.0000 | 0 | 9999.99% | 0.00% |
| Aug. 17, 2023 | McKenna Mark C. | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 17, 2023 | McKenna Mark C. | Director | A | Stock Option (Right to Buy) | 100000 | $0.00 | 150,000.0000 | 0 | 200.00% | 0.00% |
| July 13, 2023 | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Fairmount Funds Management LLC | Director | P | Common Stock | 55913 | $17.00 | 2,941,176.0000 | 0 | 1.94% | 0.00% |
| July 13, 2023 | Fairmount Funds Management LLC | Director | P | Common Stock | 1992734 | $17.00 | 2,941,176.0000 | 0 | 210.11% | 0.00% |
| July 13, 2023 | Fairmount Funds Management LLC | Director | P | Common Stock | 892529 | $17.00 | 2,941,176.0000 | 0 | 43.57% | 0.00% |
| July 13, 2023 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Shah Nimish P | Director | P | Common Stock | 1750000 | $17.00 | 1,750,000.0000 | 0 | 9999.99% | 0.00% |